Richard Wennberg

Richard Wennberg is Emeritus Professor, Neonatology, University of California, Davis and founder of Bilimetrix-USA LLC, a company dedicated to providing low cost solutions for jaundice management in low-middle income countries. He has over 80 publications focusing on bilirubin/albumin binding, bilirubin toxicity, and neonatal jaundice. He co-created the peroxidase method to measure unbound (free) bilirubin, the “Bilistick” point of care plasma bilirubin assay, and the “BiliPic” smartphone assay. He is a consultant to the “Stop Kernicterus in Nigeria” consortium and primary author of a study demonstrating the importance of maternal instruction in preventing kernicterus (Journal of Pediatrics, In Press).